Pharmacy Trends
Appeals Court Decision Favoring PCMA Leaves Questions for ERISA Plans
10 Fast Facts About the Pharmacy Benefits Industry
Protecting Your Clients Against Off-Label Ozempic
Biosimilars, GLP-1s, and Stop-loss: Topics Benefit Advisors Need to Consider in Q3 2023
Everything you need to know about 340B in 2023
The 5 Most Expensive Gene Therapies in the U.S.
State Legislation Trends Every Benefit Advisor Should Be Tracking in 2023
Prepare Your Clients for the Unpredictable
Get Our Newsletter
Stay informed with expert advice and actionable insights to optimize pharmacy benefits, reduce costs and enhance member care.
